Composition for Preventing Hair Loss or Promoting Hair Growth Comprising a Culture of Aureobasidium pullulans
Aureobasidium pullulans-based compositions enhance dermal papilla cell growth and vascular endothelial growth factor expression, addressing the inadequacies of existing hair growth agents and providing effective hair loss prevention and promotion.
Patent Information
- Application Number
- KR1020200068574
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-06-05
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2040-06-05
AI Technical Summary
Existing hair growth agents fail to predict which active ingredient produces effective hair growth results and do not demonstrate satisfactory hair growth effects, while there is a growing need for environmentally derived, bio-efficacy materials to address hair loss and promote hair growth.
A composition comprising an Aureobasidium pullulans strain, its culture, lysate, or extracts thereof, which promotes dermal papilla cell growth and vascular endothelial growth factor expression, thereby preventing hair loss and promoting hair growth.
The composition effectively promotes dermal papilla cell growth and increases vascular endothelial growth factor expression, leading to improved hair growth and hair loss prevention.
Smart Images

Figure 112020058264450-PAT00001_ABST
Abstract
Description
Technology Field
[0001] The present invention relates to Aureobasidium pullulans ( Aureobasidium pullulans The present invention relates to a composition for preventing hair loss or promoting hair growth comprising a culture of a strain, and more specifically, to a composition for preventing hair loss or promoting hair growth comprising as active ingredients an Aureobasidium pullulans strain that promotes the growth of dermal papilla cells and promotes the expression of vascular endothelial growth factor in dermal papilla cells, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture, or an extract of a lysate or a lysate. Background Technology
[0002] Each hair in the human body operates and progresses in an independent cycle, growing and shedding as it passes through the specific cycles of the anagen, catagen, and telogen phases. Generally, hair loss can be distinguished into normal telogen effluvium, where hair falls out while in the resting phase, and anagen effluvium, which is an abnormal hair loss phenomenon; the latter is specifically referred to as alopecia.
[0003] Although the exact causes of hair loss have not yet been clearly identified, genetic factors play a significant role. It is also known to be caused by poor blood circulation in the scalp, excessive activity of male hormones, excessive sebum secretion, aging, and stress. While various hair loss prevention and hair growth agents have been developed to address these diverse causes, most hair growth agents have shown some degree of effectiveness in preventing hair loss, but their effects on hair growth have not been satisfactory. Furthermore, Korean Registered Patent Publication No. 10-1467568 describes the hair growth effect of a composition that essentially contains minoxidil, a skin softener, and a skin retention agent; however, prior art, including the aforementioned patent, has the problem of failing to predict which active ingredient produces the hair growth effect and still failing to demonstrate satisfactory results.
[0004] Meanwhile, as the use of chemical and animal-derived raw materials has recently become less common, there is a growing need to find environmentally derived, bio-efficacy materials. Microbial resources are classified as sustainable resources because they can be regenerated, unlike petroleum or water; furthermore, since they utilize the unique characteristics of microorganisms adapted to diverse environments, they have very high potential for research and industrial application. Accordingly, there is a need to develop compositions containing active ingredients derived from microorganisms that exhibit excellent hair loss prevention or hair growth promotion effects.
[0005] Aureobasidium pullulans Aureobasidium pullulans Aureobasidium is one of the microorganisms of the genus Aureobasidium, also known as black yeast. Microorganisms of the genus Aureobasidium are microorganisms that produce alpha-glucan (α-glucan) and beta-glucan (β-glucan). They are found in soil and air and have excellent environmental adaptability, as they can survive and grow in environments with low humidity, high temperatures, high sunlight exposure, and even radionuclides.
[0006] In particular, Aureobasidium pullulans is a microorganism that produces pullulan, an alpha-glucan, and the produced pullulan may contain maltotriose, a trisaccharide composed of three glucose molecules connected by an α-1,4 glycosidic bond (Yurlova et al., Stud Mycol , 61:39-49, 2008; https: / / en.wikipedia.org / wiki / Pullulan reference).
[0007] While the antioxidant and skin-protective effects against atopy of pullulan, a substance produced by the Aureobasidium pullulans strain, are known, its efficacy in preventing hair loss or promoting hair growth is not known.
[0008] Specifically, there is a complete lack of research on the blood circulation improvement efficacy exhibited when the Aureobasidium pullulans strain, the culture of the strain, the lysate of the strain, the extract of the strain, the extract of the culture, or the extract of the lysate is applied to the skin, etc., and research on the efficacy of preventing hair loss or promoting hair growth through this.
[0009] Under this technical background, the inventors have completed the present invention by discovering that the Aureobasidium pullulans GJW strain (accession number KCCM12142P), the culture of said strain, the lysate of said strain, the extract of said strain, the extract of said culture, or the extract of said lysate has the efficacy of promoting the growth of dermal papilla cells and the efficacy of promoting the expression of vascular endothelial growth factor in dermal papilla cells, and that through these efficacy, said culture can be used as an active ingredient in a composition for preventing hair loss or promoting hair growth. Prior art literature
[0010] Korean Patent Publication No. 10-1467568 (Date of publication Dec. 2, 2014) The problem to be solved
[0011] The present invention has been devised to solve the above-mentioned problems, and the objective of the present invention is to provide a composition that exhibits an excellent hair loss prevention or hair growth promotion effect by including an Aureobasidium pullulans strain, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture, or an extract of a lysate of said culture as essential active ingredients, thereby promoting the growth of dermal papilla cells and promoting the expression of vascular endothelial growth factor in dermal papilla cells. means of solving the problem
[0012] To achieve the aforementioned objectives of the present invention, the present invention provides a composition for preventing hair loss or promoting hair growth, comprising as active ingredients an Aureobasidium pullulans strain, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture, or an extract of a lysate of said culture.
[0013] In addition, the present invention provides the use of an Aureobasidium pullulans strain, a culture of said strain, a lysed product of said strain, an extract of said strain, an extract of said culture, or an extract of a lysed product as an active ingredient in the preparation of a composition for preventing hair loss or promoting hair growth. Effects of the invention
[0014] According to the present invention, a composition comprising an Aureobasidium pullulans strain, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture, or an extract of a lysate of said culture as essential active ingredients promotes the growth of dermal papilla cells and promotes the expression of vascular endothelial growth factor in dermal papilla cells, thereby providing an excellent effect of preventing hair loss or promoting hair growth. Brief explanation of the drawing
[0015] Figure 1 shows that a culture extract of an Aureobasidium pullulans strain according to one embodiment of the present invention has the effect of increasing the growth (cell viability) of human dermal papilla cells. Figure 2 shows that a culture extract of an Aureobasidium pullulans strain according to one embodiment of the present invention has the effect of increasing the expression of Vascular Endothelial Growth Factor (VEGF) in dermal papilla cells. Specific details for implementing the invention
[0016] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by a skilled expert in the art to which this invention pertains. In general, the nomenclature used herein is well known and commonly used in the art.
[0017] The present invention will be described in detail below.
[0018] In this specification, the term "approximately" used to express length, area, volume, time (period), concentration, content, temperature, number, percentage (%), multiple, etc. means that there is a maximum tolerance of 10% in the corresponding numerical value or numerical range.
[0019] In one aspect, the present invention relates to Aureobasidium pullulans ( Aureobasidium pullulans The present invention relates to a composition for preventing hair loss or promoting hair growth, comprising as active ingredients a strain, a culture of the strain, a pulverized material of the strain, an extract of the strain, an extract of the culture, or an extract of the pulverized material.
[0020] The above composition may be a pharmaceutical composition for preventing hair loss or promoting hair growth, having the use of preventing or treating alopecia.
[0021] The above composition may be a cosmetic composition for preventing hair loss or promoting hair growth, having the use of improving alopecia.
[0022] In another aspect, the present invention relates to the use of an Aureobasidium pullulans strain included in the composition, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture, or an extract of a lysate included in said composition for preventing hair loss or promoting hair growth.
[0023] In another aspect, the present invention relates to a method for preventing hair loss or promoting hair growth, comprising the step of applying or administering (topically) to a subject (a mammal such as a human) a composition (preferably a cosmetic composition or a pharmaceutical composition) comprising as active ingredients an Aureobasidium pullulans strain, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture, or an extract of said lysate.
[0024] In another aspect, the present invention relates to the use of an Aureobasidium pullulans strain, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture, or an extract of a lysate of said strain for producing a pharmaceutical preparation having efficacy in preventing or treating alopecia or a cosmetic preparation having efficacy in improving alopecia.
[0025] The above pharmaceutical or cosmetic preparation may be a hair growth / hair growth promoter (improvement agent) or a hair loss prevention agent.
[0026] In another aspect, the present invention relates to the use of an Aureobasidium pullulans strain, a culture of said strain, a lysed product of said strain, an extract of said strain, an extract of said culture, or an extract of a lysed product in the preparation of a pharmaceutical composition or cosmetic composition for hair growth or hair regeneration.
[0027] The above-mentioned alopecia (or hair loss disease) may be one or more selected from alopecia areata, hereditary androgenic alopecia, telogen effluvium, traumatic alopecia, trichotillomania, pressure alopecia, anagenous alopecia, non-scarring alopecia, syphilitic alopecia, seborrheic alopecia, symptomatic alopecia, non-scarring alopecia, scarring alopecia, and congenital alopecia, depending on the form, symptoms, or cause.
[0028] Any commonly known Aureobasidium pullulans strain may be used as the above-mentioned strain, but the Aureobasidium pullulans GJW isolated and deposited by the applicant ( Aureobasidium pullulansIt is preferable to use the GJW strain.
[0029] Specifically, it is preferable to use the Aureobasidium pullulans GJW strain, which the applicant deposited with the Korean Culture Center of Microorganisms (KCCM) on October 31, 2017, under the Treaty of Budapest and was assigned the accession number KCCM12142P.
[0030] In one embodiment of the present invention, the culture of the Aureobasidium pullulans strain includes a culture medium or a culture solution, and refers to a culture product containing some or all of the substances contained in the medium in which the strain was cultured, and a concentrate thereof. For example, it may refer to a metabolic product or secretion that is a result of strain culture, or a lysate thereof, and the strain itself may also be contained in the culture.
[0031] The above culture may be cultured in a culture medium comprising all of natural media, synthetic media, or selective media, and in particular may be cultured in a culture medium comprising potato extract and dextrose. The form or formulation of the above culture is not limited and may be, for example, liquid or solid.
[0032] In one embodiment of the present invention, the culture of the Aureobasidium pullulans strain can be used in the form of a freeze-dried powder by centrifuging the culture, washing it with sterile physiological saline, dispersing it in a solvent such as sterile oil, and freeze-drying it.
[0033] In one embodiment of the present invention, the lysate of the Aureobasidium pullulans strain may be a product obtained by crushing the strain itself by chemical or physical force.
[0034] In one embodiment of the present invention, the extract may refer to a product obtained by extracting the strain itself, a culture of the strain, a lysate of the strain, or a mixture thereof, regardless of the extraction method, extraction solvent, extracted component, or form of the extract, and is a broad concept that includes all substances that can be obtained by processing or treating by other methods after extraction. Specifically, the extract may be an ethanol fraction or an ethanol precipitate.
[0035] In one embodiment of the present invention, the composition may include an Aureobasidium pullulans strain, a culture of the strain, a lysate of the strain, an extract of the strain, an extract of the culture, or an extract of the lysate as an active ingredient in an amount of 0.001 to 30% by weight based on the total weight of the composition. Specifically, the active ingredient may be included in an amount of 0.001% or more by weight, 0.01% or more by weight, 0.1% or more by weight, 0.5% or more by weight, 1.0% or more by weight, 1.5% or more by weight, or 2.0% or more by weight based on the total weight of the composition, and may be included in an amount of 30% or less by weight, 25% or less by weight, 20% or less by weight, 15% or less by weight, 10% or less by weight, or 5.0% or less by weight. If the content of the active ingredient in the above composition is less than 0.001% by weight, there is little effect of preventing hair loss or promoting hair growth (e.g., promoting the growth of hair papilla cells and promoting the expression of vascular endothelial growth factor in hair papilla cells), and if the content of the active ingredient exceeds 30% by weight, it may affect the stability of the formulation.
[0036] Meanwhile, growth factors are substances secreted by cells that can stimulate cell growth, proliferation, and differentiation. Growth factors include many types of proteins or steroid hormones and play a very important role in regulating various cells. Furthermore, growth factors act as intercellular signaling molecules, binding to specific receptors on the surface of specific cells. Types of growth factors include Keratinocyte Growth Factor (KGF) and Vascular Endothelial Growth Factor (VEGF), and these growth factors are also secreted by dermal papilla cells to aid in cell proliferation and growth.
[0037] Keratinocyte Growth Factor (KGF) is a type of fibroblast growth factor, also known as Fibroblast Growth Factor-7 (FGF-7). Fibroblast Growth Factor (FGF) promotes skin angiogenesis, thereby enhancing skin nutrient supply and elasticity, promoting the growth of hair and skin cells, and activating dermal papilla cells. Dermal papilla cells are located at the lowest part of the hair follicle and are involved in the creation and growth of hair. The proliferation of these dermal papilla cells is considered to have a doubling time of 48 hours, and the cellular activity of active substances is assessed through this proliferation. Furthermore, KGF increases hyaluronic acid synthesis in keratinocytes and promotes the biosynthesis of collagen and elastin in the dermis, thereby regulating the hair cycle to maintain hair condition and prevent hair loss.
[0038] In addition, vascular endothelial growth factor increases the permeability of plasma proteins in capillaries to promote cell division and migration, promotes the formation of new blood vessels, is involved in maintaining blood vessels, increases the size and distribution of capillaries in hair follicles, thereby increasing hair thickness and distribution and promoting hair growth.
[0039] The aforementioned keratinocyte growth factor, fibroblast growth factor, and vascular endothelial growth factor are all factors related to the growth of dermal papilla cells, and increased expression of these growth factors is important for maintaining the growth of dermal papilla cells.
[0040] The above-mentioned Aureobasidium pullulans strain, preferably Aureobasidium pullulans GJW strain (accession number KCCM12142P), a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture or an extract of said lysate can promote the growth of dermal papilla cells and can promote the expression of growth factors of dermal papilla cells, preferably vascular endothelial growth factor, and more preferably promote the expression of vascular endothelial growth factor of dermal papilla cells derived from human skin tissue.
[0041] As described above, the composition of the present invention may be a pharmaceutical composition, and said pharmaceutical composition may include a pharmaceutically acceptable carrier. The pharmaceutically acceptable carrier includes lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia gum, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methyl cellulose, microcrystalline cellulose, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate, and mineral oil, etc. Additionally, it includes diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrants, and surfactants.
[0042] The above pharmaceutical composition may be formulated in the form of oral preparations such as powders, granules, tablets, capsules, suspensions, emulsions, syrups, and aerosols, parenteral preparations, injectable preparations, and topical administration preparations according to conventional methods.
[0043] Among oral formulations, oral solid formulations include tablets, pills, powders, granules, capsules, etc., and these solid formulations may include at least one excipient, e.g., starch, calcium carbonate, sucrose or lactose, gelatin, etc., and may include lubricants such as magnesium stearate or talc. Among oral formulations, oral liquid formulations include suspensions, oral liquids, emulsions, syrups, etc., and may include diluents such as water or liquid paraffin, humectants, sweeteners, flavorings, preservatives, etc. Parenteral formulations include sterile aqueous solutions, non-aqueous solvents, suspensions, emulsions, and lyophilized formulations. Non-aqueous solvents and suspensions include propylene glycol, polyethylene glycol, vegetable oils such as olive oil, and injectable esters such as ethyl oleate.
[0044] In addition, the above pharmaceutical composition may be administered to mammals, including or not including humans, by various routes, for example, orally, intravenously, intramuscularly, or by subcutaneous injection.
[0045] The composition of the present invention may be administered topically. Topical administration means the direct application of an active ingredient or composition (such as a topical skin composition) to the skin and / or hair. The topical composition of the present invention may be in the form of a solution, lotion, paste, cream, ointment, liposome, spray, gel, foam, roller stick, or any other formulation routinely used in dermatology.
[0046] In the composition, use, and method of the present invention, the dosage of the active ingredient varies depending on the patient's condition and body weight, the severity of the disease, the form of the drug, the route of administration, the duration, etc., but can be appropriately selected as needed. The administration may be performed once a day or divided into several doses.
[0047] As described above, the composition of the present invention may be a cosmetic composition, and the cosmetic composition may be prepared in various forms according to a conventional cosmetic manufacturing method by including the Aureobasidium pullulans strain, preferably the Aureobasidium pullulans GJW strain (accession number KCCM12142P), a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture, or an extract of said lysate as an active ingredient. Specifically, the cosmetic composition may be prepared in formulations such as a hair tonic, hair cream, hair lotion, hair shampoo, hair rinse, hair conditioner, hair spray, hair aerosol, pomade, powder, gel, hair pack, hair treatment, eyebrow growth agent, eyelash growth agent, eyelash nutrient, or ointment.
[0048] In addition, the cosmetic composition may include conventional auxiliary agents such as stabilizers, solubilizers, vitamins, pigments, and fragrances commonly used in the field of cosmetic compositions, and may include a carrier acceptable for cosmetic use.
[0049] Carriers acceptable for cosmetic use include, but are not limited to, purified water, oils, waxes, fatty acids, fatty acid alcohols, fatty acid esters, surfactants, hygroscopic agents, thickeners, viscosity stabilizers, chelating agents, buffers, preservatives, lower alcohols, etc. Depending on the needs, moisturizers, anti-inflammatory agents, antibacterial agents, antifungal agents, vitamins, sunscreens, antibiotics, perfumes, and dyes may also be included.
[0050] {Example}
[0051] The present invention will be explained in detail below through examples. However, the following examples are merely illustrative to aid in the overall understanding of the present invention, and the content of the present invention is not limited to the following examples.
[0052] <Example 1> Preparation of culture extract of Aureobasidium pullulans strain
[0053] Aureobasidium pullulans GJW (which the applicant identified and deposited Aureobasidium pullulans The GJW strain [accession number KCCM12142P] was obtained from the depositary institution, the Korean Culture Center of Microorganisms (KCCM).
[0054] The above-mentioned strain was cultured in a culture medium (potato extract 4g / L, dextrose 20g / L) at a volume of 1% (v / v) (concentration of strain suspended in PBS [phosphate buffered saline]: 1.0 x 10⁶ 6 The culture was obtained by inoculating at cfu (colony forming unit) / ml and shaking incubating in a shaking incubator for 5 days under conditions of 30℃ / 120rpm. Subsequently, the culture was centrifuged to separate the cells and the culture medium (supernatant), and only the culture medium was collected. Ethanol was added to the collected culture medium in an equal volume to the culture medium and allowed to react, then left to stand at 4℃ for 1 day. Afterward, the ethanol supernatant formed by centrifugation was removed, and the precipitate was freeze-dried to obtain a culture extract of the Aureobasidium pullulans strain (Black Yeast Culture Extract).
[0055] <Test Example 1> Confirmation of the growth effect of human dermal papilla cells treated with culture extract of Aureobasidium pullulans strain
[0056] To confirm the effect of the culture extract of the Aureobasidium pullulans strain according to Example 1 (Black Yeast Culture Extract) on the growth of human dermal papilla cells, human dermal papilla cells provided by the Department of Dermatology at Dankook University were treated with the extract, and the cell viability was confirmed.
[0057] Specifically, human dermal papilla cells were cultured at 2 × 10⁶ per well using DMEM (Dulbecco's Modified Eagle Media, HyClone GE Healthcare) medium containing 10% FBS (Fetal Bovine Serum, Cambrex), 1% antibiotics, and 0.1% fungizone. 2 Cells were seeded into a 96-well plate at a density of 100 µL / 100 µL and cultured for 72 hours at 37°C under 5% CO2 humid conditions (incubator culture). After 24 hours, the culture medium used for the culture was removed from each well of the 96-well plate, and each well was washed twice with DPBS (Dulbecco's Phosphate Buffer Saline, Sigma Aldrich, USA), followed by the addition of FBS-free medium (serum-free DMEM).
[0058] Next, treatment groups were prepared by adding the extract according to Example 1 so that the final concentration per well of the 96-well plate was 10 ppm and 20 ppm, and then cultured in an incubator (37℃ / 5% CO2 humid conditions) for 72 hours, followed by treatment with CCK-8 reagent (Cell Counting Kit-8, CK04-11, Dojindo Molecular Technologies, Inc, MA, USA) for 2 hours, and then the absorbance at a wavelength of 450 nm was measured using a microplate reader to confirm cell viability.
[0059] In the positive control group, DMEM containing 5% (v / v) FBS ('5% FBS') was used instead of the extract according to Example 1. In addition, an untreated group not treated with the extract according to Example 1 or FBS was prepared as a control.
[0060] The above test was repeated three times, and the obtained test results were statistically processed and shown in Figure 1.
[0061] As shown in Figure 1, the extract treatment group according to Example 1 improved the growth of human dermal papilla cells to 25.91% and 26.87% of the control group at extract concentrations of 10 ppm and 20 ppm.
[0062] Ultimately, according to the test results of Figure 1, the culture extract of the Aureobasidium pullulans strain according to Example 1 exhibited excellent hair papilla cell growth-promoting activity, indicating that it has an excellent effect of preventing hair loss or promoting hair growth.
[0063] <Test Example 2> Confirmation of the effect of culture extract of Aureobasidium pullulans strain on increasing expression of vascular endothelial growth factor in human dermal papilla cells
[0064] To determine the effect of the culture extract of the Aureobasidium pullulans strain according to Example 1 on the expression of Vascular Endothelial Growth Factor (VEGF) in the skin, human dermal papilla cells were treated with the extract and the level of VEGF expression was checked.
[0065] 3 × 10 human dermal papilla cells 5 After seeding the wells of a 6-well plate with DMEM medium containing 10% FBS, 1% antibiotic, and 0.1% Fungizone to achieve cells / mL, a treatment group was prepared by treating the human dermal papilla cells seeded in the 6-well plate with the extract according to Example 1 at a concentration of 20 ppm, and after culturing for 48 hours, the expression level of vascular endothelial growth factor (pg / mL) was confirmed using the Human VEGF Quantikine ELISA Kit (R&D Systems, USA).
[0066] In the positive control group, 10 μM Minoxidil (MNX) was used instead of the extract according to Example 1. In addition, an untreated group not treated with the extract according to Example 1 or Minoxidil was prepared as a control.
[0067] The above test was repeated three times, and the obtained test results were statistically processed and shown in Figure 2.
[0068] As confirmed in Figure 2, the extract treatment group according to Example 1 (concentration of 20 ppm) expressed vascular endothelial growth factor in human dermal papilla cells at a level approximately 1.94 times higher than the control group and 2.28 times higher than the positive control group treated with 10 μM Minoxidil.
[0069] Ultimately, according to the test results of Figure 2, it was found that the culture extract of the Aureobasidium pullulans strain according to Example 1 has the effect of significantly increasing the expression level of vascular endothelial growth factor in hair papilla cells, thereby increasing the permeability of plasma proteins in capillaries to promote cell division and migration, promoting new angiogenesis, participating in blood vessel maintenance, increasing the size and distribution of capillaries in hair follicles, increasing hair thickness and distribution, and promoting hair growth.
[0070] Statistical processing
[0071] Statistical analysis was performed using the t-test to examine the significance between the two groups, and compared with the control group * P <0.05, ** P <0.01, *** P A difference of <0.001 was considered valid.
[0072] A composition comprising an Aureobasidium pullulans strain according to the present invention, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture, or an extract of said lysate as an active ingredient can be commercialized into various topical / cosmetic / pharmaceutical formulations, and the content ratio can be controlled to an appropriate ratio considering the functionality, cost, and other conditions of the product to be realized.
[0073] [Formulation Example 1] Tablet
[0074] A tablet was prepared according to the composition listed in Table 1 using a conventional method, comprising the Aureobasidium pullulans strain according to the present invention, a culture of the strain, a lysate of the strain, an extract of the strain, an extract of the culture, or an extract of the lysate as an active ingredient.
[0075] Ingredients Content (weight%) Aureobasidium pullulans strain according to the present invention, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture or an extract of said lysate 0.001~30 Vitamin C 2 Magnesium stearate 1 Carboxymethylcellulose calcium 2 silicon dioxide 1 Crystalline cellulose Remaining amount
[0076] [Formulation Example 2] Ointment
[0077] According to the composition listed in Table 2, an ointment was prepared by a conventional method comprising the Aureobasidium pullulans strain according to the present invention, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture, or an extract of a lysate as an active ingredient.
[0078] Ingredients Content (weight%) Aureobasidium pullulans strain according to the present invention, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture or an extract of said lysate 0.001~30 Sorbitol 9 Caprin / Capryl Triglyceride 9 Liquid paraffin 9 Sorbitan sesquioleate 6 Octyldodeces-25 9 Cetylethylhexanoate 9 Squalan 1 salicylic acid 1 glycerin 15 purified water Remaining amount
[0079] [Formulation Example 3] Lotion
[0080] A lotion was prepared according to the composition listed in Table 3 using a conventional method, comprising the Aureobasidium pullulans strain according to the present invention, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture, or an extract of a lysate as an active ingredient.
[0081] Ingredients Content (weight%) Aureobasidium pullulans strain according to the present invention, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said culture or an extract of said lysate 0.001~30 EDTA 2Na 0.2 hydroxyethylcellulose 0.5 mineral oil 5 Cetostearyl alcohol 2 Preservatives, flavors, and colors Appropriate amount purified water Remaining amount
[0082] Although the present invention has been described in relation to the preferred embodiments mentioned above, various modifications and variations are possible without departing from the essence and scope of the invention. Accordingly, the appended claims will include such modifications and variations insofar as they fall within the essence of the invention.
[0083] Depository Name: Korean Culture Collection of Microorganisms (Overseas) Trustee Number: KCCM12142P Date of Deposit: 2017-10-31
Claims
Claim 1 Aureobasidium pullulans Aureobasidium pullulans ) comprising a strain, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said strain, an extract of said culture or an extract of said lysate as active ingredients, wherein said Aureobasidium pullulans strain is Aureobasidium pullulans GJW deposited under accession number KCCM12142P ( Aureobasidium pullulans A pharmaceutical composition for preventing hair loss or promoting hair growth, which is a GJW strain and is used for the prevention or treatment of one or more types of alopecia selected from alopecia areata, telogen effluvium, traumatic alopecia, trichotillomania, pressure alopecia, anagenous alopecia, non-scarring alopecia, syphilitic alopecia, seborrheic alopecia, symptomatic alopecia, non-scarring alopecia, scarring alopecia, and congenital alopecia. Claim 2 delete Claim 3 delete Claim 4 delete Claim 5 In claim 1, the composition is a pharmaceutical composition for preventing hair loss or promoting hair growth, which promotes the growth of hair papilla cells. Claim 6 In claim 1, the composition is a pharmaceutical composition for preventing hair loss or promoting hair growth, which promotes the expression of vascular endothelial growth factor in hair papilla cells. Claim 7 A pharmaceutical composition for preventing hair loss or promoting hair growth, wherein, in any one of claims 1, 5, and 6, the composition is a topical skin composition. Claim 8 Aureobasidium pullulans Aureobasidium pullulans ) comprising a strain, a culture of said strain, a lysate of said strain, an extract of said strain, an extract of said strain, an extract of said culture or an extract of said lysate as active ingredients, wherein said Aureobasidium pullulans strain is Aureobasidium pullulans GJW deposited under accession number KCCM12142P ( Aureobasidium pullulans A cosmetic composition for preventing hair loss or promoting hair growth, which is a GJW strain, regulates the hair cycle to maintain hair condition, and increases hair thickness and distribution. Claim 9 delete Claim 10 In claim 8, the above composition is a cosmetic composition for preventing hair loss or promoting hair growth, which promotes the growth of hair papilla cells. Claim 11 In claim 8, the above composition is a cosmetic composition for preventing hair loss or promoting hair growth, which promotes the expression of vascular endothelial growth factor in hair papilla cells. Claim 12 A cosmetic composition for preventing hair loss or promoting hair growth, wherein, in any one of claims 8, 10, and 11, the composition is a skin external application composition. Claim 13 In claim 12, the formulation of the above composition is a cosmetic composition for preventing hair loss or promoting hair growth, wherein the formulation is a hair tonic, hair cream, hair lotion, hair shampoo, hair rinse, hair conditioner, hair spray, hair aerosol, pomade, powder, gel, hair pack, hair treatment, eyebrow growth agent, eyelash growth agent, eyelash nutrient, or ointment.
Citation Information
Patent Citations
Hair growth tonic
JP5085018B2
Composition for improving skin damage by fine dust comprising curture or its extract of aureobasidium pullulans
KR1020190058344A
